Clinical language exists for good reasons. It lets trained people speak precisely about anatomy, diagnosis, risk, treatment, and uncertainty. A clinician can say 'contraindication,' 'incidence,' 'noninferiority,' or 'myocardial infarction' and other clinicians know what is meant. That precision is useful inside a clinic or a paper. It becomes a problem when the same language is dropped into public communication without translation.
Translation is not the same as making the science softer. It is deciding what a reader needs in order to use the information correctly. A public article does not have to teach every detail of trial design. It does need to explain the difference between risk and certainty, symptoms and diagnosis, screening and prevention, association and cause, early research and medical advice.
The CDC's CDC Clear Communication Index is useful here because it treats clarity as something that can be assessed. It asks whether a communication product has a clear main message, uses language the intended audience can understand, explains numbers and risk, and gives people a practical sense of what to do with the information. That is a more disciplined approach than simply telling writers to 'be simple.'
A common failure is starting with the institution's structure rather than the reader's question. A health agency may want to explain the background, the committee, the program, and the data source before getting to the point. The reader often wants to know something more direct: Am I at risk? What changed? What should I do now? What should I not do yet? Who does this advice apply to?
Jargon is the visible part of the problem. Replacing 'hypertension' with 'high blood pressure' helps. Replacing 'adverse event' with 'side effect' may help in some contexts. But the harder issue is conceptual jargon. People may know the words in a sentence and still miss the claim. 'The association remained significant after adjustment' is made of ordinary words, but it is not public language.
Numbers need special care. Percentages can be accurate and still hard to interpret. A risk that doubles may sound frightening, but if it doubles from 1 in 10,000 to 2 in 10,000, the public meaning is different from a change from 1 in 10 to 2 in 10. Absolute risk, baseline risk, and time frame should appear whenever the numbers are central to the claim.
Screening is a good example. A test can detect disease earlier and still create tradeoffs: false positives, false negatives, overdiagnosis, anxiety, follow-up procedures, cost, and unequal access. If public communication says only that screening 'saves lives,' it may be directionally true for some tests and populations, but it leaves out the reason screening guidelines are often age-specific and risk-specific.
Uncertainty should be named, but not used as fog. Public writing often hides behind phrases like 'more research is needed.' Sometimes that is true and useful. Often it is too vague. Better wording explains what kind of uncertainty remains: the study was short, the sample was small, the population was narrow, the outcome was indirect, or the result has not been repeated.
Tone matters too. Health communication can become either frightening or patronizing. Fear can get attention, but it can also make people tune out, freeze, or distrust the message. A patronizing tone can make a reader feel blamed for constraints they did not choose. A clearer style respects the reader's time and gives enough context for a real decision.
Plain language does not mean every sentence must be short. It means the reader should not have to decode the sentence before reaching the idea. A long sentence can work if the structure is clean. A short sentence can fail if it uses unexplained technical terms. The test is whether the likely reader can understand the point the first time through.
Good research translation also avoids false certainty. A study may suggest, estimate, test, compare, or find an association. Those verbs are not interchangeable. 'Proves' should be rare. 'Linked to' should not be turned into 'causes.' 'May reduce risk' should not become 'prevents.' The verb is part of the evidence.
Public language should also say what not to do. If a finding is early, say not to change medication without a clinician. If an intervention was tested only in a high-risk group, say not to assume it applies to everyone. If a supplement has a signal of benefit but uncertain safety, say that. The absence of a warning often becomes permission in the reader's mind.
The best health communication leaves the reader with a usable shape of the evidence. What was studied? What changed? How large was the change? Who does it apply to? What remains uncertain? Where can a reader go next? That structure does not make the research less serious. It makes it harder to misuse.
Moving from clinic language to public language is not a cosmetic step at the end of the process. It is part of the health intervention. If people cannot understand the message, they cannot act on it well. If they misunderstand the message, they may act with confidence in the wrong direction. Clarity is not decoration. It is part of the evidence reaching the person it was supposed to help.